Background >Levomilnacipran extended release (ER) is a serotonin and norepinephri'/> <meta property="og:document:type" content="pdf"/> <meta property="og:document:page" content="10"/> <meta name="Robots" contect="all"> <meta name="citation_title" content="Relapse prevention with levomilnacipran ER in adults with major depressive disorder: A multicenter, randomized, double‐blind, placebo‐controlled study"> <meta name="citation_author" content="Durgam Suresh"><meta name="citation_author" content="Chen Changzheng"><meta name="citation_author" content="Migliore Raffaele"><meta name="citation_author" content="Prakash Chandran"><meta name="citation_author" content="Thase Michael E."> <meta name="citation_publication_date" content="2019"> <meta name="citation_journal_title" content="Depression and anxiety"> <meta name="citation_volume" content="36"> <meta name="citation_issue" content="3"> <link rel="canonical" href="https://www.zhangqiaokeyan.com/journal-foreign-detail/0704025195538.html"/> <link rel="shortcut icon" href="https://cdn.zhangqiaokeyan.com/favicon.ico"> <link rel="alternate" media="only screen and (max-width: 640px)" href="https://m.zhangqiaokeyan.com/journal-foreign-detail/0704025195538.html"/> <title>Relapse prevention with levomilnacipran ER in adults with major depressive disorder: A multicenter, randomized, double‐blind, placebo‐controlled study
首页> 外文期刊>Depression and anxiety >Relapse prevention with levomilnacipran ER in adults with major depressive disorder: A multicenter, randomized, double‐blind, placebo‐controlled study
【24h】

Relapse prevention with levomilnacipran ER in adults with major depressive disorder: A multicenter, randomized, double‐blind, placebo‐controlled study

机译:随着主要抑郁症的成年人中左旋硝基吡普兰欧尔的复发预防:多中心,随机,双盲,安慰剂对照研究

获取原文
获取原文并翻译 | 示例
           

摘要

Background >Levomilnacipran extended release (ER) is a serotonin and norepinephrine reuptake inhibitor approved for major depressive disorder (MDD) in adults. This study was designed to evaluate relapse prevention with levomilnacipran ER in patients with MDD. </section> <section xml:id="da22872-sec-0020"> <title type="main">Methods > Patients (≥18 years) with MDD ( N ?=?644) received 20?weeks of open‐label treatment with levomilnacipran ER 40, 80, or 120?mg/d (8?weeks flexible dosing; 12?weeks fixed dosing). Patients with a Montgomery–?sberg Depression Rating Scale (MADRS) total score ≤12 from the end of week 8 to week 20 were randomized to 26 weeks of double‐blind treatment with levomilnacipran ER (same dosage; n ?=?165) or placebo ( n ?=?159). The primary efficacy endpoint was time to relapse, defined as insufficient therapeutic response (≥2‐point increase from randomization in Clinical Global Impression of Severity score, risk of suicide, need for hospitalization due to worsening of depression, or need for alternative antidepressant treatment as determined by the investigator) or an MADRS total score ≥18 at 2 consecutive visits. </section> <section xml:id="da22872-sec-0030"> <title type="main">Results > In the double‐blind intent‐to‐treat population, levomilnacipran ER‐treated patients had a significantly longer time to relapse compared with placebo (hazard ratio?=?0.56; 95% CI, 0.33–0.92; P? =?0.0212). Crude relapse rates were 14.5% (levomilnacipran ER) and 24.5% (placebo). Double‐blind treatment‐emergent adverse events (AEs) were reported for 58.8% and 56.0% of levomilnacipran ER and p </span> <span class="z_kbtn z_kbtnclass hoverxs" style="display: none;">展开▼</span> </div> <div class="translation abstracttxt"> <span class="zhankaihshouqi fivelineshidden" id="abstract"> <span>机译:</span><Abstract Type =“main”XML:lang =“en”> <部分XML:ID =“DA22872-SEC-0010”> <标题类型=“main”>背景</ title> > Levomilnacipran扩展释放(er )是一名血清素和去甲肾上腺素再摄取抑制剂,用于成人的主要抑郁症(MDD)。本研究旨在评估MDD患者的Levomilnacipran ER复发预防。</ p> </ section> <section XML:ID =“DA22872-SEC-0020”> <标题类型=“main”>方法</标题> >患者(≥18岁),MDD( n </ i>?=Δ444)接受20个,用Levomilnacipran ER 40,80或120?mg / d(8 ?周灵活给药; 12?周固定剂量)。蒙哥马利 - ?SBERG抑郁率刻度(MADRS)总分≤12从第8周结束到第20周的26周,用Levomilnacipran ER(相同剂量; n </ i >?=?165)或安慰剂( n </ i>?=?159)。初级疗效终点是复发的时间,定义为治疗反应不足(≥2点从随机化因严重程度评分的临床全球印象中的随机性增加,因抑郁而导致的自杀风险,需要住院,或者需要替代抗抑郁药治疗由调查人员决定)或MADRS总得分≥18连续一次访问。 </ p> </ section> <section XML:ID =“da22872-ec-0030”> <标题类型=“main”>结果</ title> >在双盲意向治疗群体中,与安慰剂(危险比?= 0.56; 95%CI,0.33-0.92; = 0.0212)。原油复发率为14.5%(Levomilnacipran ER)和24.5%(安慰剂)。据报告双盲治疗 - 急促不良事件(AES)为58.8%和56.0%的Levomilnacipran和P. </span> <span class="z_kbtn z_kbtnclass hoverxs" style="display: none;">展开▼</span> </div> </div> <div class="record"> <h2 class="all_title" id="enpatent33" >著录项</h2> <ul> <li> <span class="lefttit">来源</span> <div style="width: 86%;vertical-align: text-top;display: inline-block;"> <a href='/journal-foreign-32884/'>《Depression and anxiety》</a> <b style="margin: 0 2px;">|</b><span>2019年第3期</span><b style="margin: 0 2px;">|</b><span>共10页</span> </div> </li> <li> <div class="author"> <span class="lefttit">作者</span> <p id="fAuthorthree" class="threelineshidden zhankaihshouqi"> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=Durgam Suresh&option=202" target="_blank" rel="nofollow">Durgam Suresh;</a> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=Chen Changzheng&option=202" target="_blank" rel="nofollow">Chen Changzheng;</a> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=Migliore Raffaele&option=202" target="_blank" rel="nofollow">Migliore Raffaele;</a> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=Prakash Chandran&option=202" target="_blank" rel="nofollow">Prakash Chandran;</a> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=Thase Michael E.&option=202" target="_blank" rel="nofollow">Thase Michael E.;</a> </p> <span class="z_kbtnclass z_kbtnclassall hoverxs" id="zkzz" style="display: none;">展开▼</span> </div> </li> <li> <div style="display: flex;"> <span class="lefttit">作者单位</span> <div style="position: relative;margin-left: 3px;max-width: 639px;"> <div class="threelineshidden zhankaihshouqi" id="fOrgthree"> <p>AllerganMadison New Jersey;</p> <p>AllerganMadison New Jersey;</p> <p>AllerganMadison New Jersey;</p> <p>AllerganMadison New Jersey;</p> <p>University of Pennsylvania Health SystemPhiladelphia Pennsylvania;</p> </div> <span class="z_kbtnclass z_kbtnclassall hoverxs" id="zhdw" style="display: none;">展开▼</span> </div> </div> </li> <li > <span class="lefttit">收录信息</span> <span style="width: 86%;vertical-align: text-top;display: inline-block;"></span> </li> <li> <span class="lefttit">原文格式</span> <span>PDF</span> </li> <li> <span class="lefttit">正文语种</span> <span>eng</span> </li> <li> <span class="lefttit">中图分类</span> <span>R749.72; </span> </li> <li class="antistop"> <span class="lefttit">关键词</span> <p style="width: 86%;vertical-align: text-top;"> <a style="color: #3E7FEB;" href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=antidepressant&option=203" rel="nofollow">antidepressant;</a> <a style="color: #3E7FEB;" href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=depression&option=203" rel="nofollow">depression;</a> <a style="color: #3E7FEB;" href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=levomilnacipran extended release&option=203" rel="nofollow">levomilnacipran extended release;</a> <a style="color: #3E7FEB;" href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=long‐term treatment&option=203" rel="nofollow">long‐term treatment;</a> <a style="color: #3E7FEB;" href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=maintenance treatment&option=203" rel="nofollow">maintenance treatment;</a> <a style="color: #3E7FEB;" href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=randomized withdrawal&option=203" rel="nofollow">randomized withdrawal;</a> </p> <div class="translation"> 机译:抗抑郁药;抑郁症;Levomilnacipran延长释放;长期治疗;维护治疗;随机撤离; </div> </li> </ul> </div> </div> <div class="literature cardcommon"> <div class="similarity "> <h3 class="all_title" id="enpatent66">相似文献</h3> <div class="similaritytab clearfix"> <ul> <li class="active" >外文文献</li> <li >中文文献</li> <li >专利</li> </ul> </div> <div class="similarity_details"> <ul > <li> <div> <b>1. </b><a class="enjiyixqcontent" href="/journal-foreign-detail/0704025195538.html">Relapse prevention with levomilnacipran ER in adults with major depressive disorder: A multicenter, randomized, double‐blind, placebo‐controlled study</a> <b>[J]</b> . <span> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=Durgam Suresh&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">Durgam Suresh,</a> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=Chen Changzheng&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">Chen Changzheng,</a> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=Migliore Raffaele&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">Migliore Raffaele,</a> <a href="/journal-foreign-32884/" target="_blank" rel="nofollow" class="tuijian_authcolor">Depression and anxiety .</a> <span>2019</span><span>,第3期</span> </span> </div> <p class="zwjiyix translation" style="max-width: initial;height: auto;word-break: break-all;white-space: initial;text-overflow: initial;overflow: initial;"> <span>机译:随着主要抑郁症的成年人中左旋硝基吡普兰欧尔的复发预防:多中心,随机,双盲,安慰剂对照研究</span> </p> </li> <li> <div> <b>2. </b><a class="enjiyixqcontent" href="/journal-foreign-detail/0704015293382.html">Levomilnacipran ER 40 mg and 80 mg in patients with major depressive disorder: A phase III, randomized, double-blind, fixed-dose, placebo-controlled study</a> <b>[J]</b> . <span> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=BakishD.&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">BakishD.,</a> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=BoseA.&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">BoseA.,</a> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=GommollC.&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">GommollC.,</a> <a href="/journal-foreign-35664/" target="_blank" rel="nofollow" class="tuijian_authcolor">Journal of psychiatry & neuroscience: JPN .</a> <span>2014</span><span>,第1期</span> </span> </div> <p class="zwjiyix translation" style="max-width: initial;height: auto;word-break: break-all;white-space: initial;text-overflow: initial;overflow: initial;"> <span>机译:患有严重抑郁症的左旋米那普仑ER 40 mg和80 mg:III期,随机,双盲,固定剂量,安慰剂对照研究</span> </p> </li> <li> <div> <b>3. </b><a class="enjiyixqcontent" href="/academic-journal-foreign_detail_thesis/0204117756128.html">A randomized, double-blind, placebo-controlled study of flexible doses of levomilnacipran ER (40–120?mg/day) in patients with major depressive disorder</a> <b>[J]</b> . <span> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=Carl P. Gommoll&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">Carl P. Gommoll,</a> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=William M. Greenberg&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">William M. Greenberg,</a> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=Changzheng Chen&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">Changzheng Chen </a> <a href="/journal-foreign-34197/" target="_blank" rel="nofollow" class="tuijian_authcolor">Journal of Drug Assessment .</a> <span>2014</span><span>,第1期</span> </span> </div> <p class="zwjiyix translation" style="max-width: initial;height: auto;word-break: break-all;white-space: initial;text-overflow: initial;overflow: initial;"> <span>机译:轻度重度抑郁症患者左旋米那普仑ER(40–120?mg /天)的弹性剂量的随机,双盲,安慰剂对照研究</span> </p> </li> <li> <div> <b>4. </b><a class="enjiyixqcontent" href="/academic-conference-foreign_meeting-225278_thesis/020516260924.html">The effect of tDCS on ERD potentials: A randomized, double-blind placebo controlled study</a> <b>[C]</b> . <span> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=Izzidien A.&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">Izzidien A.,</a> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=Ramaraju S.&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">Ramaraju S.,</a> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=Roula M.A.&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">Roula M.A.,</a> <a href="/conference-foreign-225278/" target="_blank" rel="nofollow" class="tuijian_authcolor">IEEE Symposium on Computational Intelligence, Cognitive Algorithms, Mind, and Brain .</a> <span>2014</span> </span> </div> <p class="zwjiyix translation" style="max-width: initial;height: auto;word-break: break-all;white-space: initial;text-overflow: initial;overflow: initial;"> <span>机译:tDCS对ERD电位的影响:一项随机,双盲安慰剂对照研究</span> </p> </li> <li> <div> <b>5. </b><a class="enjiyixqcontent" href="/academic-degree-foreign_mphd_thesis/02061463755.html">A Randomized, Double-Blind, Placebo-Controlled Crossover Trial Evaluating the Effect of Intranasal Insulin on Cognition and Emotional Processing in Individuals with Treatment-Resistant Major Depressive Disorder.</a> <b>[D] </b> . <span> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=Cha, Danielle Soh-Young.&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">Cha, Danielle Soh-Young. </a> <span>2016</span> </span> </div> <p class="zwjiyix translation" style="max-width: initial;height: auto;word-break: break-all;white-space: initial;text-overflow: initial;overflow: initial;"> <span>机译:一项随机,双盲,安慰剂对照的交叉试验评估了鼻内胰岛素对难治性重度抑郁症患者认知和情绪加工的影响。</span> </p> </li> <li> <div> <b>6. </b><a class="enjiyixqcontent" href="/academic-journal-foreign-pmc_wiley-blackwell-online-open_thesis/040004928010.html">Relapse prevention with levomilnacipran ER in adults with major depressive disorder: A multicenter randomized double‐blind placebo‐controlled study</a> <b>[O] </b> . <span> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=Suresh Durgam&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">Suresh Durgam,</a> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=Changzheng Chen&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">Changzheng Chen,</a> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=Raffaele Migliore&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">Raffaele Migliore,</a> <span>-1</span> </span> </div> <p class="zwjiyix translation" style="max-width: initial;height: auto;word-break: break-all;white-space: initial;text-overflow: initial;overflow: initial;"> <span>机译:患有严重抑郁症的成人使用左旋米那普仑ER预防复发:一项多中心随机双盲安慰剂对照研究</span> </p> </li> <li> <div> <b>7. </b><a class="enjiyixqcontent" href="/open-access_resources_thesis/01000129479883.html">A randomized, double-blind, placebo-controlled study of flexible doses of levomilnacipran ER (40–120 mg/day) in patients with major depressive disorder</a> <b>[O] </b> . <span> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=Carl P. Gommoll&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">Carl P. Gommoll,</a> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=William M. Greenberg&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">William M. Greenberg,</a> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=Changzheng Chen&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">Changzheng Chen </a> <span>2014</span> </span> </div> <p class="zwjiyix translation" style="max-width: initial;height: auto;word-break: break-all;white-space: initial;text-overflow: initial;overflow: initial;"> <span>机译:主要抑郁症患者柔性剂量脐带氏菌(40-120 mg /天)的随机,双盲,安慰剂对照研究</span> </p> </li> </ul> <ul style="display: none;"> <li> <div> <b>1. </b><a class="enjiyixqcontent" href="/academic-journal-cn_journal-clinical-psychiatry_thesis/0201237171858.html">艾司西酞普兰与西酞普兰治疗抑郁症的随机、双盲对照研究</a> <b>[J]</b> <span> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=吕振雷&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor"> . 吕振雷</a> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=张云彪&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">,张云彪</a> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=祁曙光&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">,祁曙光</a> <span> <a href="/journal-cn-6241/" target="_blank" rel="nofollow" class="tuijian_authcolor"> . 临床精神医学杂志 </a> </span> <span> . 2013</span><span>,第001期</span> </span> </div> </li> <li> <div> <b>2. </b><a class="enjiyixqcontent" href="/academic-journal-cn_journal-china-prescription-drug_thesis/0201293068739.html">托吡酯治疗慢性下腰痛:一项随机、双盲、安慰剂对照研究</a> <b>[J]</b> <span> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=菅鑫妍&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor"> . 菅鑫妍</a> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=于丽&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">,于丽</a> <span> <a href="/journal-cn-6413/" target="_blank" rel="nofollow" class="tuijian_authcolor"> . 中国处方药 </a> </span> <span> . 2006</span><span>,第11期</span> </span> </div> </li> <li> <div> <b>3. </b><a class="enjiyixqcontent" href="/academic-journal-cn_world-latest-medicine-information_thesis/0201285809584.html">随机双盲安慰剂对照研究评价0.77环吡酮凝胶对趾间足癣(皮肤复合真菌病)的疗效</a> <b>[J]</b> <span> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=trialGupta A.K.&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor"> . trialGupta A.K.</a> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=Skinner A.R.&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">,Skinner A.R.</a> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=Cooper E.A.&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">,Cooper E.A.</a> <span> <a href="/journal-cn-6287/" target="_blank" rel="nofollow" class="tuijian_authcolor"> . 世界核心医学期刊文摘:皮肤病学分册 </a> </span> <span> . 2005</span><span>,第012期</span> </span> </div> </li> <li> <div> <b>4. </b><a class="enjiyixqcontent" href="/academic-journal-cn_world-latest-medicine-information_thesis/0201285810502.html">左旋咪唑治疗局限性和缓慢扩散性白癜风的随机双盲安慰剂对照研究</a> <b>[J]</b> <span> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=Agarwal S&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor"> . Agarwal S</a> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=Ramam M&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">,Ramam M</a> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=Sharma V.K&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">,Sharma V.K</a> <span> <a href="/journal-cn-6287/" target="_blank" rel="nofollow" class="tuijian_authcolor"> . 世界核心医学期刊文摘:皮肤病学分册 </a> </span> <span> . 2005</span><span>,第010期</span> </span> </div> </li> <li> <div> <b>5. </b><a class="enjiyixqcontent" href="/academic-journal-cn_letters-biotechnology_thesis/0201295909089.html">重组5型腺病毒载体埃博拉疫苗在中国健康成年人中的免疫持续性和同源初免-加强免疫:一项随机、双盲、安慰剂对照Ⅰ期临床试验的最终报告</a> <b>[J]</b> <span> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor"> . </a> <span> <a href="/journal-cn-5085/" target="_blank" rel="nofollow" class="tuijian_authcolor"> . 生物技术通讯 </a> </span> <span> . 2017</span><span>,第1期</span> </span> </div> </li> <li> <div> <b>6. </b><a class="enjiyixqcontent" href="/academic-conference-cn_meeting-26464_thesis/020221632411.html">芎芍胶囊预防冠心病介入治疗后再狭窄的多中心随机双盲安慰剂对照研究</a> <b>[C]</b> <span> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=陈可冀&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor"> . 陈可冀</a> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=史大卓&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">,史大卓</a> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=徐浩&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">,徐浩</a> <span> <a href="/conference-cn-26464/" target="_blank" rel="nofollow" class="tuijian_authcolor"> . 第六次全国中西医结合血瘀证及活血化瘀研究学术大会 </a> <span> <span> . 2005</span> </span> </div> </li> <li> <div> <b>7. </b><a class="enjiyixqcontent" href="/academic-degree-domestic_mphd_thesis/020316050682.html">养心血颗粒治疗慢性心力衰竭的有效性和安全性的多中心、随机、双盲、安慰剂对照研究</a> <b>[A] </b> <span> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=唐丹&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor"> . 唐丹</a> <span> . 2020</span> </span> </div> </li> </ul> <ul style="display: none;"> <li> <div> <b>1. </b><a class="enjiyixqcontent" href="/patent-detail/06130415399250.html">Methods and Compositions for Treatment and Prevention of Major Depressive Disorder</a> <b>[P]</b> . <span> 外国专利: <!-- 美国专利: --> US2015010534A1 </span> <span> . 2015-01-08</span> </div> <p class="zwjiyix translation" style="max-width: initial;height: auto;word-break: break-all;white-space: initial;text-overflow: initial;overflow: initial;"> <span>机译:治疗和预防重度抑郁症的方法和成分 </span> </p> </li> <li> <div> <b>2. </b><a class="enjiyixqcontent" href="/patent-detail/06130425921728.html">Methods and compositions for treatment and prevention of major depressive disorder</a> <b>[P]</b> . <span> 外国专利: <!-- 美国专利: --> US2011091444A1 </span> <span> . 2011-04-21</span> </div> <p class="zwjiyix translation" style="max-width: initial;height: auto;word-break: break-all;white-space: initial;text-overflow: initial;overflow: initial;"> <span>机译:治疗和预防重度抑郁症的方法和组合物 </span> </p> </li> <li> <div> <b>3. </b><a class="enjiyixqcontent" href="/patent-detail/06130432825057.html">Pharmaceutical composition containing saredutant with a selective serotonin reuptake inhibitor or an inhibitor of the reuptake of serotonin / norepinephrine; and use in Prevention andThe Treatment of major depressive disorder.</a> <b>[P]</b> . <span> 外国专利: <!-- --> CL2007002217A1 </span> <span> . 2008-03-07</span> </div> <p class="zwjiyix translation" style="max-width: initial;height: auto;word-break: break-all;white-space: initial;text-overflow: initial;overflow: initial;"> <span>机译:药物组合物,其含有含有选择性5-羟色胺再摄取抑制剂或5-羟色胺/去甲肾上腺素再摄取抑制剂的芥子酸;并用于预防和治疗重度抑郁症。 </span> </p> </li> </ul> </div> </div> </div> <div class="theme cardcommon" style="overflow: auto;display:none"> <h3 class="all_title" id="enpatent55">相关主题</h3> <ul id="subject"> </ul> </div> </div> </div> </div> <div class="right rightcon"> <div class="details_img cardcommon clearfix" style="margin-bottom: 10px;display:none;" > </div> </div> </div> <div id="thesis_get_original1" class="downloadBth" style="bottom: 19px;z-index: 999;" onclick="ywcd('0704025195538','4',7,2,1,'',this,24)" class="delivery" prompt="010401" title="通过人工服务将文献原文发送至邮箱" >获取原文</div> <div class="journalsub-pop-up" style="display: none"> <div class="journal-sub"> <h2>期刊订阅</h2> <img src="https://cdn.zhangqiaokeyan.com/img/loginclose.png" alt="" onclick="$('.journalsub-pop-up').hide()"> <p class="pardon">抱歉,该期刊暂不可订阅,敬请期待!</p> <p class="current">目前支持订阅全部北京大学中文核心(2020)期刊目录。</p> <div style="display: flex;margin-top: 69px;justify-content: space-between;"> <div class="no-sub" onclick="$('.journalsub-pop-up').hide()">暂不订阅</div> <div class="other-sub" onclick="continueSub('from=pc-detail')">继续订阅其他期刊</div> </div> </div> </div> <div class="right_btn"> <ul> <li class="gouwuche"> <!-- <a href="javascript:void(0);" onclick="link_analysis('/shoppingcart/auth/list.html',this)">购物车</a>--> </li> <li class="yijian"> <a href="javascript:void(0);" onclick="link_analysis('/mycenter/auth/complaint.html',this)">意见反馈</a> </li> <li class="top"> <a href="javascript:scrollTo(0,0);">回到顶部</a> </li> <li class="shouye"> <a href="/">回到首页</a> </li> </ul> </div> <div class="xllindexfooter"> <div class="xllindexfootercenter"> <div class="xllindexfooterleft left" > <div class="xllindexfooterleftli"> <ul> <li><a href="/about.html">关于掌桥</a></li> <li><a href="/help/helpmap.html">资源导航</a></li> <li><a href="/help/helpguide.html">新手指南</a></li> <li><a href="/help/helpcenter.html">常见问题</a></li> <li><a href="/sitemap.html">网站地图</a></li> <li><a href="/help/helpcenter.html?type=9">版权声明</a></li> </ul> </div> <div class="xllindexfooterleft"> <p class="xllindexfooterlefteamil">客服邮箱:kefu@zhangqiaokeyan.com</p> <div class="xllindexfooterlefttcp"> <div class="xllindexfooterpoliceiimg"></div> <div class="xllindexfooterpoliceispan"> <span>京公网安备:11010802029741号 </span> <span>ICP备案号:<a href="https://beian.miit.gov.cn" rel="nofollow" target="_blank">京ICP备15016152号-6</a></span> <span>六维联合信息科技 (北京) 有限公司©版权所有</span> </div> </div> </div> </div> <div class="xllindexfooterright left"> <ul> <li> <p style="font-weight: bold;">客服微信</p> <div></div> </li> <li> <p style="font-weight: bold;">服务号</p> <div></div> </li> </ul> </div> </div> </div> <span id="0704025195538down" data-source="7," data-out-id="6VAdtQDk5JWEU9C+0wQ0DDxDnAUdPy5Kcu3HMd40VuYyQTnRRlKV3k+mPOsgaCmD," data-f-source-id="7" data-title="Relapse prevention with levomilnacipran ER in adults with major depressive disorder: A multicenter, randomized, double‐blind, placebo‐controlled study" data-price="20" data-site-name="" data-transnum="24" style="display:none;"></span> <input type="hidden" value="4" id="sourcetype"> <input type="hidden" value="32884" id="journalid"> <input type="hidden" value="1" id="inyn_provide_service_level"> <input type="hidden" value="https://cdn.zhangqiaokeyan.com" id="imgcdn"> <input type="hidden" value="1" id="isdeatail"> <input type="hidden" value="" id="syyn_indexed_database"> <input type="hidden" value="" id="servicetype"> <input type="hidden" id="pagename" value="Relapse prevention with levomilnacipran ER in adults with major depressive disorder: A multicenter, randomized, double‐blind, placebo‐controlled study"/> <input type="hidden" value="thesis_get_original" id="pageIdentification"> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/jquery-1.12.4.js"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/common/lwlh_ajax.js"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/zq.js?v=5.7.7"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/common/common.js?v=5.7.7"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/jquery.cookie.js"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/top.js?v=5.7.7"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/common/tip.js?v=5.7.7"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/common/login.js?v=5.7.7"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/common/down.js?v=5.7.7"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/common/search.js?v=5.7.7"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/searchtype.js?v=5.7.7"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/user/regist.js?v=5.7.7"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/zxs_solor/detail.js?v=5.7.7"></script> <script type="text/javascript" src="https://www.zhangqiaokeyan.com/statistics/static/pagecollection.js"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/tj.js"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/pushbaidu.js"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/common/history.js"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/util/cookie.js?v=5.7.7"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/weipu/weipu.js?v=5.7.7"></script> </body> <script> $(function(){ var weiPuStatus = getCookie('WeiPuStatus'); if(weiPuStatus){ tipWeiPuStatus(weiPuStatus); delCookie('WeiPuStatus'); } getFacetKeywordVoInId(); var sourcetype = $("#sourcetype").val(); var inyn_provide_service_level = $("#inyn_provide_service_level").val(); if((sourcetype ==1||sourcetype==4)&&inyn_provide_service_level!=4){ getJournal(); } }) </script> </html>